ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) Financial Statements
ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) files with the U.S. Securities and Exchange Commission under CIK 0002023311. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2025
- Revenue
- 574.12 million CNY
- Net Income
- -1.24 billion CNY
- Net Cash from Operations
- -1.17 billion CNY
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Apr 29, 2026. Source: SEC filings (EDGAR XBRL). Amounts in CNY.
Open the full financial statements for AAPG in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History